https://www.ema.europa.eu/en/medicines/human/EPAR/lonapegsomatropin-ascendis-pharma 2022 false false false Netherlands French English Lonapegsomatropin Lonapegsomatropin treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation child adolescent orphan drug production drug approval europe Growth Hormone Deficiency growth hormone injections, subcutaneous lonapegsomatropin product surveillance, postmarketing drug interactions pregnancy breast feeding prodrugs drug evaluation, preclinical